To further validate the therapeutic effect of lapatinib on CRC with high NSUN2 expression, a xenograft model was established in nude mice through the subcutaneous implantation of NSUN2 overexpression DLD1 cells. The gene discussed is NSUN2; the disease is colorectal carcinoma.